Moleculera Labs Video and Audio Interviews

Prescriber Portal Login

Moleculera Labs is a leading developer and provider of cutting-edge testing services that assist in identifying individuals with infection-induced autoimmune disorders. Passionate about raising awareness of these perplexing conditions, Moleculera executives are always available for interviews with the media.

KOCO – Doctors believe strep infection could be factor in some children’s behavior disordersResearchers in Oklahoma City are investigating whether the strep infection could play a factor in some behavior disorders in children.

KFOR – PANDAS Awareness Day and Moleculera LabsDr. Craig Shimasaki, President and CEO of Moleculera Labs, and parents of children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Strep infections (PANDAS) speak out at PANDAS Awareness Day at the Oklahoma State Capitol on October 6, 2016.

KFOR – Did you know strep throat can give your child mental illness?Five-year-old Grace Harper from Oklahoma is featured in a story about Pediatric Autoimmune Neuropsychiatric Disorder Associated with Strep infections (PANDAS). The young girl suffered from a sudden onset of OCD and bouts of rage following a strep infection.

BioTech Nation Radio
Diagnosing some behavioral problems and mental disorders in young people by testing their immune system?Dr. Craig Shimasaki, President and CEO of Moleculera Labs, discusses the relationship between mental illnesses and immune dysfunction and explains how the Cunningham Panel of tests can help identify children with these complex infection-induced autoimmune encephalopathies.

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

The Journal RecordMoleculera Labs wins the 2013 Innovator of the Year Award, presented by The Journal Record, based in Oklahoma. Dr. Craig Shimasaki, CEO of Moleculera, gives a passionate acceptance speech.

Stay Updated

B. Robert Mozayeni, MD

Medical and Clinical Advisor

Dr. B. Robert Mozayeni was trained in Internal Medicine and Rheumatology at Yale and at NIH. He has had pre- and post-doctoral Fellowships in Molecular Biophysics and Biochemistry at Yale, and also at NIH where he was a Howard Hughes Research Scholar at LMB/DCBD/NCI and later, Senior Staff Fellow at LMMB/NHLBI/NIH. Editorial board of Infectious Diseases – Surveillance, Prevention and Treatment. Past President of the International Lyme and Associated Diseases Society (ILADS).

He is an expert in Translational Medicine, the science and art of advancing medical science safely and efficiently. He is a Fellow of the non-profit Think Lead Innovate Foundation and is a co-founder of the Foundation for the Study of Inflammatory Diseases. He is a Founder of the Foundation for the Study of Inflammatory Diseases to crowd-source medical solutions for complex conditions using existing knowledge, diagnostic methods, and therapies to meet patient needs immediately. He is the Chief Medical Officer of Galaxy Diagnostics, LLC. He is a Board member of the Human-Kind Alliance. Dr. Mozayeni has held admitting privileges (since 1994) on the clinical staff of Suburban Hospital, a member of Johns Hopkins Medicine and an affiliate of the National Institutes of Health Clinical Center.

Safedin Sajo Beqaj, PhD, HCLD, CC (ABB)

Moleculera Labs, Clinical Laboratory Advisor

Medical Database, Inc., President and CEO

Dr. Sajo Beqaj is board certified in molecular pathology and genetics and licensed as a Bioanalyst and High Complexity Laboratory Director. He has been practicing as a laboratory director since 2005.

Dr. Beqaj served as a technical director and was part of the initial management team for several well-known laboratories in the clinical lab industry including PathGroup, Nashville, TN; DCL Medical Laboratories, Indianapolis, IN, and Pathology, Inc, Torrance, CA. He is currently serving as off-side CLIA laboratory director for BioCorp Clinical Laboratory, Whittier, CA and Health360 Labs, Garden Grove, CA.

Dr. Beqaj received his Ph.D. in Pathology from Wayne State University Medical School, Detroit, Michigan. He performed his post-doctoral fellowship at Abbott Laboratories from 2001-2003 and with Children’s Hospital and Northwestern University from 2003-2005.

Dr. Beqaj has taught in several academic institutions and has published numerous medical textbook chapters and journal articles. He has served as a principal investigator in clinical trials for several well-known pharmaceutical and diagnostic companies such as Roche HPV Athena, Merck HPV vaccine, BD vaginitis panel, Roche (Vantana) CINtec® Histology clinical trials, and has presented various scientific clinical abstracts and presentations.

He is a member of several medical and scientific associations including the Association of Molecular Pathology, American Association of Clinical Chemistry and the Pan Am Society for Clinical Virology. He has served on a number of clinical laboratory regulatory and scientific committees, and has assisted several laboratories and physicians as a Clinical Laboratory Consultant.